Stay updated on THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Sign up to get notified when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.

Latest updates to the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page
- Check3 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 access error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe site revision label changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with a generic error view. This indicates an access issue rather than a content update.SummaryDifference15%

- Check31 days agoChange DetectedA new revision label v3.7.0 was added. The previous revision label v3.6.6 was removed.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page shows a new revision label, updating from v3.6.5 to v3.6.6, which indicates a minor update to the page or its underlying system. This change does not introduce any visible content changes to the user.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study identifiers section now includes '2016 ( U.S. NIH Grant/Contract )', indicating NIH funding for the THALES trial. This addition does not modify the study content or how a user would interact with the page.SummaryDifference0.0%

Stay in the know with updates to THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.